Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides

被引:182
作者
Mai, A
Massa, S
Pezzi, R
Simeoni, S
Rotili, D
Nebbioso, A
Scognamiglio, A
Altucci, L
Loidl, P
Brosch, G
机构
[1] Univ Roma La Sapienza, Dipartimento Studi Farmaceut, Inst Pasteur, I-00185 Rome, Italy
[2] Univ Siena, Dipartimento Farmaco Chim Tecnol, I-53100 Siena, Italy
[3] Seconda Univ Studi Napoli, Dipartimento Patol Gen, I-80138 Naples, Italy
[4] AIRC, CEINGE, Ctr Oncogen, Naples, Italy
[5] Univ Innsbruck, Dept Mol Biol, A-6020 Innsbruck, Austria
关键词
D O I
10.1021/jm049002a
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Chemical manipulations performed on aroyl-pyrrolyl-hydroxyamides (APHAs) led to (aryloxopropenyl)pyrrolyl hydroxamates 2a-w, and their inhibition against maize HDACs and their class I or class II HDAC selectivity were determined. In particular, from these studies some benzene meta-substituted compounds emerged as highly class II (IIa)-selective HDAC inhibitors, the most selective being the 3-chloro- and 3-fluoro-substituted compounds 2c (SI = 71.4) and 2f (SI = 176.4). The replacement of benzene with a 1-naphthyl ring afforded 2s, highly active against the class II homologue HD1-A (IC50 = 10 nM) but less class II-selective than 2c,f When tested against human HDAC1 and HDAC4, 2f showed no inhibitory activity against HDAC1 but was able to inhibit HDAC4. Moreover, in human U937 acute myeloid leukaemia cells 2f did not produce any effect on apoptosis, granulocytic differentiation, and the cell cycle, whereas 2s (that retain class I HDAC inhibitory activity) was 2-fold less potent than SAHA used as reference.
引用
收藏
页码:3344 / 3353
页数:10
相关论文
共 86 条
[31]   Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation [J].
Haggarty, SJ ;
Koeller, KM ;
Wong, JC ;
Grozinger, CM ;
Schreiber, SL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (08) :4389-4394
[32]   Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs [J].
Hassig, CA ;
Schreiber, SL .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1997, 1 (03) :300-308
[33]   A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression [J].
Heinzel, T ;
Lavinsky, RM ;
Mullen, TM ;
Soderstrom, M ;
Laherty, CD ;
Torchia, J ;
Yang, WM ;
Brard, G ;
Ngo, SD ;
Davie, JR ;
Seto, E ;
Eisenman, RN ;
Rose, DW ;
Glass, CK ;
Rosenfeld, MG .
NATURE, 1997, 387 (6628) :43-48
[34]   HDAC6 is a microtubule-associated deacetylase [J].
Hubbert, C ;
Guardiola, A ;
Shao, R ;
Kawaguchi, Y ;
Ito, A ;
Nixon, A ;
Yoshida, M ;
Wang, XF ;
Yao, TP .
NATURE, 2002, 417 (6887) :455-458
[35]   Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer [J].
Johnstone, RW .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) :287-299
[36]   Inhibitors of histone deacetylase as new anticancer agents [J].
Jung, M .
CURRENT MEDICINAL CHEMISTRY, 2001, 8 (12) :1505-1511
[37]   Isolation and characterization of mammalian HDAC10, a novel histone deacetylase [J].
Kao, HY ;
Lee, CH ;
Komarov, A ;
Han, CC ;
Evans, RM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (01) :187-193
[38]   Histone deacetylase inhibitors: from target to clinical trials [J].
Kelly, WK ;
O'Connor, OA ;
Marks, PA .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (12) :1695-1713
[39]  
KIJIMA M, 1993, J BIOL CHEM, V268, P22429
[40]   Different types of maize histone deacetylases are distinguished by a highly complex substrate and site specificity [J].
Kölle, D ;
Brosch, G ;
Lechner, T ;
Pipal, A ;
Helliger, W ;
Taplick, J ;
Loidl, P .
BIOCHEMISTRY, 1999, 38 (21) :6769-6773